Intergroupe Francophone Du Myelome
Clinical trials sponsored by Intergroupe Francophone Du Myelome, explained in plain language.
-
New study monitors Teclistamab's Real-World impact on Hard-to-Treat myeloma
Disease control OngoingThis study follows 200 adults with multiple myeloma that has come back or stopped responding to treatment. Researchers are tracking how well the drug teclistamab works and what side effects occur when used in everyday medical practice. The main goal is to see how many patients ac…
Sponsor: Intergroupe Francophone du Myelome • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Pee breakthrough: One-Cup test could replace Day-Long urine jug for myeloma patients
Diagnosis OngoingThis study checks if a single urine sample (spot urine) can detect myeloma proteins as well as the standard 24-hour urine collection. About 180 multiple myeloma patients starting a new treatment will provide both types of samples. If the spot test proves accurate, it could make m…
Sponsor: Intergroupe Francophone du Myelome • Aim: Diagnosis
Last updated May 26, 2026 10:24 UTC